- Report
- March 2023
- 126 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- July 2024
- 156 Pages
Global
From €3868EUR$4,250USD£3,316GBP
- Report
- April 2024
- 88 Pages
United States
From €997EUR$1,095USD£854GBP
- Report
- January 2025
- 132 Pages
Global
From €865EUR$950USD£741GBP
- Report
- September 2024
- 310 Pages
Global
From €2416EUR$2,655USD£2,071GBP
- Report
- November 2023
- 240 Pages
Global
From €3249EUR$3,570USD£2,785GBP
- Book
- August 2022
- 736 Pages
- Book
- April 2021
- 592 Pages
- Book
- October 2010
- 606 Pages
The Blood Product market is a subset of the Blood Banking industry, which involves the collection, processing, storage, and distribution of blood and blood components. Blood products are derived from human blood and are used to treat a variety of medical conditions. These products include red blood cells, platelets, plasma, and cryoprecipitate. Red blood cells are used to treat anemia, while platelets are used to treat bleeding disorders. Plasma is used to treat shock, and cryoprecipitate is used to treat clotting disorders.
The Blood Product market is highly regulated, with stringent safety and quality standards in place to ensure the safety of the products. The market is also highly competitive, with a number of companies offering a variety of products. Some of the major players in the market include CSL Behring, Grifols, Octapharma, Kedrion, and Biotest. Show Less Read more